Click here to see how our firm is preparing for COVID-19.
How can we help?

    Allergan Breast Implant Lawyer

    In 2019, the United States Food and Drug Administration (FDA) requested that the drug manufacturer Allergan issue a recall for its line of textured breast implants. This recall followed years of concern that these implants contributed to forms of lymphatic cancer.

    If you suffer from a form of lymphatic cancer following a breast implant procedure, you might be entitled to financial compensation. A dedicated mass torts attorney could review your medical records and advise you if the manufacturer has recalled the breast implants used in your procedure.

    Many patients are unaware of the recall or the associated cancer risks that come with these implants. To learn what your next move should be, discuss your case with an Allergan breast implant lawyer right away.

    The Allergan Breast Implant Recall

    In 2019, the FDA issued a notice requesting a recall of all BIOCELL textured breast implants manufactured by the drug company Allergan. However, the issues with these breast implants began well before 2019. The first links between Allergan breast implants and the increased risk of lymphatic cancer were reported in 2011. By July of 2019, Allergan had fully recalled all BIOCELL textured breast implants. Someone who is unsure of whether their particular breast implant was part of the Allergan recall should speak with an attorney.

    Understanding BIA-ALCL

    Allergan breast implants are linked to a specific form of lymphatic cancer. This cancer is known as “breast implant-associated anaplastic large cell lymphoma,” or BIA-ALCL. This is not a form of breast cancer. Instead, it is a rare type of cancer that targets the immune system, known as T-cell lymphoma.

    This form of cancer is linked directly with the use of textured implants during cosmetic breast enlargement or post-mastectomy procedures. To date, this form of cancer has only occurred in women with textured breast implants or those who have had textured breast implants in the past.

    BIA-ALCL develops in the scar tissue and the fluid that surrounds a breast implant. Although it is serious, BIA-ALCL is treatable when it is detected in its early stages. Unfortunately, this form of cancer has proven to be fatal in some cases.

    According to the analysis provided by the FDA, the vast majority of BIA-ALCL cases worldwide result from the implantation of an Allergan device. In total, Allergan implants are tied to 481 of the 573 worldwide fatalities reported by the FDA.

    Legal Options Following the Recall

    An experienced attorney could explain legal options to a BIA-ALCL patient following an Allergan breast plant procedure. There are multiple paths to recover compensation related to these defective products.

    The first option involves a direct lawsuit against the makers of the BIOCELL textured breast implants. By suing Allergan directly, a plaintiff has full control of how their legal claim progresses. However, facing off against a large pharmaceutical company in an individual lawsuit can be costly.

    The second option is to take part in a class-action claim against Allergan. A class-action lawsuit involves a class of plaintiffs in a similar situation combining their claims against Allergan into a single lawsuit. No individual member of the class will have direct control over the case against Allergan but the cost of pursuing these claims is shared between the many plaintiffs.

    Speak with an Allergan Breast Implant Attorney

    Although many people survive BIA-ALCL, this form of cancer can have long-lasting effects on all who are diagnosed with it. If you are living with BIA-ALCL, you are entitled to hold Allergan accountable for their product through a civil lawsuit, potentially as a class action.

    Let an Allergan breast implant lawyer guide you through the process of filing a claim. Call right away to talk about your legal options.